Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-22T18:45:10.017Z Has data issue: false hasContentIssue false
  • English
  • Français

Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging?

Published online by Cambridge University Press:  19 July 2012

James O'Donovan ,
Rosie Watson ,
Sean J. Colloby ,
Michael J. Firbank ,
Emma J. Burton ,
Robert Barber ,
Andrew. M. Blamire  and
John T. O'Brien
James O'Donovan
Affiliation:
Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
Rosie Watson
Affiliation:
Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
Sean J. Colloby*
Affiliation:
Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
Michael J. Firbank
Affiliation:
Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
Emma J. Burton
Affiliation:
Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
Robert Barber
Affiliation:
Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
Andrew. M. Blamire
Affiliation:
Newcastle Magnetic Resonance Centre and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE4 5PL, UK
John T. O'Brien
Affiliation:
Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
*
Correspondence should be addressed to: Dr Sean Colloby, Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK. Phone: +44 191 248 1321; Fax: +44 191 248 1301. Email: [email protected].
Get access

Abstract

Background: Previous studies suggest that posterior cortical atrophy may be a useful marker for early onset Alzheimer's disease (AD). Dementia with Lewy bodies (DLB) is associated with less temporal lobe atrophy than AD, though posterior cortical atrophy may be greater. Therefore, we assessed whether visual rating scales for assessing posterior atrophy (PA), medial temporal lobe atrophy (MTA), and ventricular enlargement (VEn) aid in the discrimination between AD, DLB, and normal aging.

Methods: T1-weighted MRI scans acquired at 3 Tesla were visually rated for PA (range 0–3), MTA (range 0–4), and VEn (range 0–3) in older subjects with AD (n = 36), DLB (n = 35), and healthy controls (n = 35). The diagnostic utility of MTA, PA, and VEn visual ratings in distinguishing AD and DLB from controls as well as AD from DLB was investigated.

Results: Significantly higher MTA ratings were associated with AD and DLB compared to controls (p < 0.001). MTA ratings were greater in AD relative to DLB (U = 384.5, p = 0.004). For PA ratings, scores did not differ between groups (p = 0.20). VEn ratings were significantly higher in AD and DLB compared to controls (p = 0.003), but similar between AD and DLB (U = 384.5, p = 0.4).

Conclusions: Unlike findings reported in younger subjects, visual ratings for PA are not a reliable marker at older ages for distinguishing AD from controls, or for distinguishing DLB from AD. However, visual ratings of MTA and VEn may be useful markers in distinguishing both AD and DLB from older subjects without dementia.

Keywords

Alzheimer's diseasedementia with Lewy bodiesMRI
Type
Research Article
Information
International Psychogeriatrics , Volume 25 , Issue 1 , January 2013 , pp. 111 - 119
Copyright
Copyright © International Psychogeriatric Association 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barber, R., Gholkar, A., Scheltens, P., Ballard, C., McKeith, I. G. and O'Brien, J. T. (1999). Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology, 52, 1153–1158.CrossRefGoogle ScholarPubMed
Barnes, J.et al. (2007). Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiology of Aging, 28, 20–28.CrossRefGoogle ScholarPubMed
Bastos-Leite, A. J., Van Der Flier, W. M., Van Straaten, E. C. W., Staekenborg, S. S., Scheltens, P. and Barkhof, F. (2007). The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke, 38, 3182–3185.CrossRefGoogle ScholarPubMed
Beyer, M. K., Larsen, J. P. and Aarsland, D. (2007). Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology, 69, 47–754.CrossRefGoogle ScholarPubMed
Bucks, R. S., Ashworth, D. L., Wilcock, G. K. and Siegfried, K. (1996). Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing, 25, 113–120.CrossRefGoogle ScholarPubMed
Burton, E. J.et al. (2009). Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain, 132, 195–203.CrossRefGoogle ScholarPubMed
Colloby, S. J.et al. (2002). A comparison of 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal of Nuclear Medicine, 29, 615–622.CrossRefGoogle ScholarPubMed
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308–2314.CrossRefGoogle ScholarPubMed
Dubois, B.et al. (2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. Lancet Neurology, 6, 734–746.CrossRefGoogle ScholarPubMed
Fahn, S. and Elton, R. (1987). Unified Parkinson's Disease Rating Scale. In Fahn, S., Marsden, C. D., Goldstein, M. and Calne, D. B. (eds.), Recent Development in Parkinson's Disease (pp. 153–164). Florham Park, NJ: Macmillan Health Care Information.Google Scholar
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle ScholarPubMed
Frisoni, G. B., Testa, C., Sabattoli, F., Beltramello, A., Soininen, H. and Laakso, M. P. (2005). Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. Journal of Neurology, Neurosurgery and Psychiatry, 76, 112–114.CrossRefGoogle ScholarPubMed
Frisoni, G. B.et al. (2007). The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain, 130, 720–730.CrossRefGoogle ScholarPubMed
Galton, C. J., Patterson, K., Xuereb, J. H. and Hodges, J. R. (2000). Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain, 123, 484–498.CrossRefGoogle ScholarPubMed
Goldman, W. P.et al. (2001). Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology, 56, 361–367.CrossRefGoogle ScholarPubMed
Hodges, J. R. (2006). Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain, 129, 2811–2822.CrossRefGoogle ScholarPubMed
Hort, J.et al. (2010). EFNS guidelines for the diagnosis and management of Alzheimer's disease. European Journal of Neurology, 17, 1236–1248.CrossRefGoogle ScholarPubMed
Ishii, K., Yamaji, S., Kitagaki, H., Imamura, T., Hirono, N. and Mori, E. (1999). Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology, 53, 413–416.CrossRefGoogle ScholarPubMed
Karas, G.et al. (2007). Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology, 49, 967–976.CrossRefGoogle ScholarPubMed
Koedam, E. L. G. E.et al. (2011). Visual assessment of posterior atrophy development of a MRI rating scale. European Radiology, 21, 2618–2625.CrossRefGoogle ScholarPubMed
Lehmann, M.et al. (2011). Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiology of Aging, 33, 627.e1–627.e12.Google ScholarPubMed
Lippa, C. F.et al. (2007). DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology, 68, 812–819.CrossRefGoogle ScholarPubMed
Lobotesis, K.et al. (2001). Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology, 56, 643–649.CrossRefGoogle Scholar
McKeith, I. G.et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113–1124.CrossRefGoogle Scholar
McKeith, I.et al. (2004). Dementia with Lewy bodies. Lancet Neurology, 3, 19–28.CrossRefGoogle ScholarPubMed
McKeith, I. G.et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology, 65, 1863–1872.CrossRefGoogle ScholarPubMed
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.CrossRefGoogle ScholarPubMed
McKhann, G. M.et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia, 7, 263–269.CrossRefGoogle ScholarPubMed
Rodrigue, K. M.et al. (2012). β-amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology, 78, 387–395.CrossRefGoogle ScholarPubMed
Scheltens, P.et al. (1992). Atrophy of medial temporal lobes on MRI in ‘‘probable’’ Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. Journal of Neurology, Neurosurgery and Psychiatry, 55, 967–972.CrossRefGoogle ScholarPubMed
Scheltens, P., Pasquier, F., Weerts, J. G. E., Barkhof, F. and Leys, D. (1997). Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. European Neurology, 37, 95–99.CrossRefGoogle ScholarPubMed
Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clinical Gerontologist, 5, 165–173.Google Scholar
Sperling, R. A.et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia, 7, 280–292.CrossRefGoogle ScholarPubMed
Terry, R. D.et al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30, 572–580.CrossRefGoogle ScholarPubMed
Watson, R., Blamire, A. M. and O'Brien, J. T. (2009). Magnetic resonance imaging in Lewy body dementias. Dementia and Geriatric Cognitive Disorders, 28, 493–506.CrossRefGoogle ScholarPubMed
Watson, R., O'Brien, J. T., Barber, R. and Blamire, A. M. (2012). Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. International Psychogeriatrics, 24, 532–540.CrossRefGoogle ScholarPubMed
Whitwell, J. L.et al. (2007). Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain, 130, 708–719.CrossRefGoogle ScholarPubMed